Sharma, Ashish
Khanani, Arshad M.
Parachuri, Nikulaa
Kumar, Nilesh
Bandello, Francesco
Kuppermann, Baruch D.
Article History
Received: 11 January 2023
Accepted: 25 January 2023
First Online: 30 January 2023
Declarations
:
: Not required.
: Yes.
: <b>Ashish Sharma:</b> Consultant: for Novartis, Allergan, Bayer, Lupin and Intas, Speaker fee Biogen.<b>Arshad M Khanani:</b> Consultant: Abbvie<b>,</b> Adverum Biotechnologies, AGTC, Alimera Sciences, Allergan, Apellis Pharmaceuticals, Arrowhead, Pharmaceuticals, AsclepiX Therapeutics, Aviceda Therapeutics, Bausch & Lomb, BroadWing Bio, Cholgene Therapeutics, 4D Molecular Therapeutics, Eyepoint Pharmaceuticals, Fronterra Therapeutics, Gemini Pharmaceuticals, Genentech, Graybug Vision, Gyroscope Therapeutics, Iveric Bio, Janssen Pharmaceuticals, Kato Pharmaceuticals, Kartos Therapeutics, Kodiak Sciences, Kriya Therapeutics, Ocular Therapeutix, Oculis, Ocuterra, Opthea, Oxurion, Novartis, Perfuse, PolyPhotonix, Ray Therapeutics, Recens Medical, Regeneron Pharmaceuticals, REGENXBIO, Roche, Stealth Biotherapeutics Therapeutics, Thea Pharma, UNITY Biotechnology, Vanotech.<b>Research Support:</b> Adverum Biotechnologies, Annexon Biosciences, Apellis Pharmaceuticals, AsclepiX Therapeutics, 4D Molecular Therapeutics, Gemini Pharmaceuticals, Genentech, Graybug Vision, Gyroscope Therapeutics, Iveric Bio, Janssen Pharmaceuticals, Kodiak, Neurotech, NGM Biopharmaceuticals, Novartis, Ocular Therapeutix, Oculis, Ocuterra, Opthea, Oxurion, Recens Medical, REGENXBIO, Roche, UNITY Biotechnology.<b>Speaker:</b> Abbvie, Apellis, Genentech, Novartis.<b>Financial:</b> Aviceda Therapeutics, PolyPhotonix, Recens Medical.<b>Nikulaa parachuri:</b> None.<b>Nilesh Singh:</b> Speaker-Intas, Lupin.<b>Francesco Bandello:</b> Consultant: Allergan, Bayer, Boehringer- Ingelheim, FidiaSooft, Hofmann La Roche, Novartis, NTC Pharma, Sifi, Thrombogenics, Zeiss.<b>Baruch D Kuppermann:</b> CLINICAL RESEARCH: Alcon, Alimera, Allegro, Allergan, Apellis, Clearside, Genentech, GSK, Ionis, jCyte, Novartis, Regeneron, ThromboGenics; CONSULTANT: Alimera, Allegro, Allergan, Cell Care, Dose, Eyedaptic, Galimedix, Genentech, Glaukos, Interface Biologics, jCyte, Novartis, Ophthotech, Regeneron, Revana, Theravance Biopharma.